CVS Health's poor 2024 performance could be turning around in 2025 with a new CEO and potential rebound, despite challenges.

We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...

Patient Capital Management, a value investing firm, released its “Patient Capital Opportunity Equity Strategy” fourth quarter ...

CVS operates 25 sites in San Jose, with another one roughly two miles from the recently sold site. The 5407 Camden Ave.

Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are ...

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

CVS’ efforts to reform how its pharmacies are paid have reached a significant milestone that should stabilize flagging ...

Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...

Bernstein analyst Lance Wilkes maintained a Hold rating on CVS Health (CVS – Research Report) yesterday and set a price target of $52.00. The ...